Next Article in Journal
Prevalence of anterior knee pain among patients following total knee arthroplasty with nonreplaced patella: A retrospective study of 1778 knees
Previous Article in Journal
Moving into the wide clinical spectrum of consciousness disorders: Pearls, perils and pitfalls
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessReview

Familial hematuria: A review

1
Department of Medical Genetics, University Hospital Ostrava, Ostrava, Czechia
2
Department of Paediatrics, Hospital Česká Lípa, Česká Lípa, Czechia
3
Department of Pediatrics, Motol University Hospital and 2nd Faculty of Medicine, Charles University in Prague, Prague, Czechia
*
Author to whom correspondence should be addressed.
Medicina 2017, 53(1), 1-10; https://doi.org/10.1016/j.medici.2017.01.002
Received: 20 July 2016 / Revised: 23 December 2016 / Accepted: 16 January 2017 / Published: 31 January 2017
The most frequent cause of familial glomerular hematuria is thin basement membrane nephropathy (TBMN) caused by germline COL4A3 or COL4A4 gene mutations. Less frequent but important cause with respect to morbidity is Alport syndrome caused by germline COL4A5 gene mutations. The features of Alport syndrome include hematuria, proteinuria and all males with X-linked disease and all individuals with recessive disease will develop end stage renal disease, usually at early youth. In X-linked Alport syndrome, a clear genotype-phenotype correlation is typically observed in men. Deleterious COL4A5 mutations are associated with a more severe renal phenotype and more frequent high-frequency sensorineural hearing loss and ocular abnormalities. Less severe COL4A5 mutations result in a milder phenotype, with less frequent and later onset extrarenal anomalies. The phenotype in females is highly variable, mostly due to inactivation of one of the X chromosomes. Isolated cases may be caused by de novo COL4A5 mutations or by gonosomal mosaicism. Untreated autosomal recessive Alport syndrome, caused by COL4A3 and COL4A4 mutations, is typically associated with ESRD at the age of 23–25 years and extrarenal symptoms in both men and women. The TBMN phenotype is associated with heterozygous carriers of COL4A3, COL4A4 mutations. Molecular genetic testing is the gold standard for diagnosing these diseases. Although genotype-phenotype correlations exist, the phenotype is influenced by modifying factors, which remain mainly undefined. No therapy is available that targets the cause of Alport syndrome; angiotensin-converting enzyme inhibitor therapy delays renal failure and improves lifespan.
Keywords: Alport syndrome; Thin basement membrane nephropathy; Familial glomerular hematuria; COL4A4; COL4A5 Alport syndrome; Thin basement membrane nephropathy; Familial glomerular hematuria; COL4A4; COL4A5
MDPI and ACS Style

Plevová, P.; Gut, J.; Janda, J. Familial hematuria: A review. Medicina 2017, 53, 1-10.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Back to TopTop